Mereo BioPharma Group (MREO) News Today $3.35 +0.06 (+1.82%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Mereo BioPharma Group (NASDAQ:MREO) Hits New 1-Year Low - Should You Sell?Mereo BioPharma Group (NASDAQ:MREO) Sets New 12-Month Low - Here's What HappenedDecember 20 at 3:06 PM | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Sees Strong Trading Volume - What's Next?Mereo BioPharma Group (NASDAQ:MREO) Sees Strong Trading Volume - What's Next?December 18 at 1:53 PM | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Stock Price Down 4.5% - Time to Sell?Mereo BioPharma Group (NASDAQ:MREO) Shares Down 4.5% - What's Next?December 16, 2024 | marketbeat.comMereo BioPharma Group plc (NASDAQ:MREO) Receives $7.50 Average PT from AnalystsDecember 11, 2024 | americanbankingnews.comMereo BioPharma Group (NASDAQ:MREO) Raised to Strong-Buy at Cantor FitzgeraldCantor Fitzgerald upgraded Mereo BioPharma Group to a "strong-buy" rating in a report on Sunday.December 10, 2024 | marketbeat.comMereo BioPharma Group plc (NASDAQ:MREO) Shares Purchased by Frazier Life Sciences Management L.P.Frazier Life Sciences Management L.P. boosted its holdings in shares of Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) by 15.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,097,779 shares of thDecember 10, 2024 | marketbeat.comMereo Biopharma Group Plc: Strong Buy Rating Due to Promising Pipeline and Strategic PartnershipsDecember 6, 2024 | markets.businessinsider.comJefferies Initiates Coverage of Mereo BioPharma Group plc - Depositary Receipt () (MREO) with Buy RecommendationDecember 6, 2024 | msn.comMereo BioPharma Group (NASDAQ:MREO) Shares Gap Up - Still a Buy?Mereo BioPharma Group (NASDAQ:MREO) Shares Gap Up - Still a Buy?December 6, 2024 | marketbeat.comMereo BioPharma Group plc (NASDAQ:MREO) Given Average Recommendation of "Buy" by BrokeragesShares of Mereo BioPharma Group plc (NASDAQ:MREO - Get Free Report) have been given a consensus rating of "Buy" by the five analysts that are currently covering the company, MarketBeat.com reports. Four equities research analysts have rated the stock with a buy recommendation and one has issued aDecember 6, 2024 | marketbeat.comJefferies Financial Group Begins Coverage on Mereo BioPharma Group (NASDAQ:MREO)Jefferies Financial Group began coverage on Mereo BioPharma Group in a research report on Friday. They set a "buy" rating and a $7.00 target price on the stock.December 6, 2024 | marketbeat.comJanus Henderson Group PLC Purchases 4,464,984 Shares of Mereo BioPharma Group plc (NASDAQ:MREO)Janus Henderson Group PLC lifted its position in Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) by 56.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 12,345,866 shares of the company's stock after purchasing an adDecember 6, 2024 | marketbeat.comAcuta Capital Partners LLC Has $5.18 Million Position in Mereo BioPharma Group plc (NASDAQ:MREO)Acuta Capital Partners LLC increased its stake in shares of Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) by 86.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,260,700 shares of the company's stock aNovember 28, 2024 | marketbeat.comMereo BioPharma: Setrusumab Chugs Along With Possible Inflection PointsNovember 26, 2024 | seekingalpha.comWhat is Leerink Partnrs' Forecast for MREO FY2024 Earnings?Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) - Stock analysts at Leerink Partnrs issued their FY2024 EPS estimates for Mereo BioPharma Group in a research report issued on Monday, November 18th. Leerink Partnrs analyst J. Schwartz anticipates that the company will post earnings of $0.06November 21, 2024 | marketbeat.comWhat is Leerink Partnrs' Forecast for MREO Q1 Earnings?Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) - Analysts at Leerink Partnrs issued their Q1 2025 earnings per share estimates for Mereo BioPharma Group in a report released on Monday, November 18th. Leerink Partnrs analyst J. Schwartz expects that the company will post earnings per shareNovember 20, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Reaches New 52-Week Low - Time to Sell?Mereo BioPharma Group (NASDAQ:MREO) Hits New 52-Week Low - Here's What HappenedNovember 15, 2024 | marketbeat.comMereo Biopharma Group Plc: Positive Developments and Strong Growth Potential Justify Buy RatingNovember 14, 2024 | markets.businessinsider.comPositive Outlook for Mereo Biopharma Group Plc Amidst Promising Therapeutic Developments and Strong Financial PositionNovember 14, 2024 | markets.businessinsider.comMereo BioPharma to Participate in Fireside Chat at the Jefferies London Healthcare ConferenceNovember 14, 2024 | globenewswire.comMereo BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNovember 12, 2024 | globenewswire.comMereo BioPharma Group (NASDAQ:MREO) Shares Down 4.4% - Time to Sell?Mereo BioPharma Group (NASDAQ:MREO) Stock Price Down 4.4% - Here's WhyNovember 4, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Stock Price Down 6.4% - Here's WhyMereo BioPharma Group (NASDAQ:MREO) Shares Down 6.4% - Time to Sell?October 23, 2024 | marketbeat.comIs Mereo BioPharma Group (MREO) the Hottest Penny Stock to Invest in According to Hedge Funds?October 16, 2024 | msn.comMillennium Management LLC Buys 1,022,570 Shares of Mereo BioPharma Group plc (NASDAQ:MREO)Millennium Management LLC grew its stake in shares of Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) by 46.9% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,201,705 shares of the company's stock aOctober 8, 2024 | marketbeat.comMarshall Wace LLP Takes Position in Mereo BioPharma Group plc (NASDAQ:MREO)Marshall Wace LLP bought a new position in Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 1,144,051 shares of the company's stock, valued at approximately $October 3, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Given "Overweight" Rating at Cantor FitzgeraldCantor Fitzgerald restated an "overweight" rating and set a $7.00 price objective on shares of Mereo BioPharma Group in a research report on Tuesday.October 1, 2024 | marketbeat.comPerceptive Advisors LLC Invests $4.51 Million in Mereo BioPharma Group plc (NASDAQ:MREO)Perceptive Advisors LLC bought a new stake in Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 1,253,250 shares of the company's stock, valued at approximatSeptember 30, 2024 | marketbeat.comFrazier Life Sciences Management L.P. Makes New Investment in Mereo BioPharma Group plc (NASDAQ:MREO)Frazier Life Sciences Management L.P. bought a new position in Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 4,401,371 shares of the company's stock, valued at approximSeptember 29, 2024 | marketbeat.comBlue Owl Capital Holdings LP Takes $3.23 Million Position in Mereo BioPharma Group plc (NASDAQ:MREO)Blue Owl Capital Holdings LP acquired a new stake in shares of Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 897,809 shares of the company's stock, valued at approSeptember 28, 2024 | marketbeat.comDeerfield Management Company L.P. Series C Invests $24.16 Million in Mereo BioPharma Group plc (NASDAQ:MREO)Deerfield Management Company L.P. Series C acquired a new stake in shares of Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 6,710,September 26, 2024 | marketbeat.comIntegral Health Asset Management LLC Has $6.39 Million Stock Holdings in Mereo BioPharma Group plc (NASDAQ:MREO)Integral Health Asset Management LLC increased its position in Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) by 86.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,775,000 shares of the company'September 23, 2024 | marketbeat.comRubric Capital Management LP Grows Position in Mereo BioPharma Group plc (NASDAQ:MREO)Rubric Capital Management LP grew its stake in shares of Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) by 12.9% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 15,307,347 shares of the company's stock after purchasing an additiSeptember 21, 2024 | marketbeat.comMereo BioPharma Group plc (MREO): A Bull Case TheorySeptember 18, 2024 | msn.comMereo BioPharma Group (NASDAQ:MREO) Shares Gap Up to $3.95Mereo BioPharma Group (NASDAQ:MREO) Shares Gap Up to $3.95September 18, 2024 | marketbeat.comJohn A. Lewicki Sells 5,212 Shares of Mereo BioPharma Group plc (NASDAQ:MREO) StockSeptember 17, 2024 | insidertrades.comCantor Fitzgerald Reaffirms Overweight Rating for Mereo BioPharma Group (NASDAQ:MREO)Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $7.00 price target on shares of Mereo BioPharma Group in a report on Monday.September 16, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Sees Unusually-High Trading VolumeMereo BioPharma Group (NASDAQ:MREO) Sees Large Volume IncreaseSeptember 13, 2024 | marketbeat.comMereo BioPharma to Participate in Fireside Chat at the 2024 Cantor Global Healthcare ConferenceSeptember 12, 2024 | globenewswire.comMereo BioPharma Group (NASDAQ:MREO) Trading Down 4.9%Mereo BioPharma Group (NASDAQ:MREO) Shares Down 4.9%September 12, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Shares Up 3.3%Mereo BioPharma Group (NASDAQ:MREO) Stock Price Up 3.3%September 10, 2024 | marketbeat.comMereo BioPharma Group plc (NASDAQ:MREO) Director Deepika Pakianathan Sells 105,244 SharesAugust 24, 2024 | insidertrades.comInsider Selling: Mereo BioPharma Group plc (NASDAQ:MREO) Director Sells 105,244 Shares of StockMereo BioPharma Group plc (NASDAQ:MREO - Get Free Report) Director Deepika Pakianathan sold 105,244 shares of the business's stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $4.43, for a total transaction of $466,230.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.August 23, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Trading 5.8% Higher Mereo BioPharma Group (NASDAQ:MREO) Stock Price Up 5.8%August 23, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Reaches New 12-Month High at $4.55Mereo BioPharma Group (NASDAQ:MREO) Sets New 1-Year High at $4.55August 22, 2024 | marketbeat.comStrong Buy Rating for Mereo Biopharma Amidst Promising Drug Program DevelopmentsAugust 16, 2024 | markets.businessinsider.comBuy Rating Affirmed for Mereo Biopharma on Strong Financials and Promising Pipeline ProgressAugust 16, 2024 | markets.businessinsider.comMereo BioPharma Group (NASDAQ:MREO) Stock Price Up 4.9%Mereo BioPharma Group (NASDAQ:MREO) Trading Up 4.9%August 16, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Stock Price Down 2.8%Mereo BioPharma Group (NASDAQ:MREO) Stock Price Down 2.8%August 15, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Reaches New 12-Month High at $3.82Mereo BioPharma Group (NASDAQ:MREO) Sets New 12-Month High at $3.82August 14, 2024 | marketbeat.com Get Mereo BioPharma Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MREO and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin MREO Media Mentions By Week MREO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MREO News Sentiment▼0.430.60▲Average Medical News Sentiment MREO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MREO Articles This Week▼32▲MREO Articles Average Week Get Mereo BioPharma Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MREO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AKRO News Today AMPH News Today TARS News Today IRON News Today CGON News Today HRMY News Today GLPG News Today XNCR News Today EVO News Today ARQT News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MREO) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mereo BioPharma Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Mereo BioPharma Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MREO Stock Alerts